Found: 5
Select item for more details and to access through your institution.
Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.
- Published in:
- Scientific Reports, 2016, p. 22404, doi. 10.1038/srep22404
- By:
- Publication type:
- Article
Dopamine D1 Receptor Gene Variation Modulates Opioid Dependence Risk by Affecting Transition to Addiction.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070805
- By:
- Publication type:
- Article
Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056053
- By:
- Publication type:
- Article
Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.
- Published in:
- Neurochemical Research, 2016, v. 41, n. 6, p. 1375, doi. 10.1007/s11064-016-1841-0
- By:
- Publication type:
- Article
Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0196023
- By:
- Publication type:
- Article